RSS

Pseudomonas aeruginosa (P. aeruginosa)

Clinical-stage biotechnology company, Visterra, has been awarded a research and development contract from the public-private partnership, Combating Antibiotic Resistant Bacteria Accelerator (CARB-X). more

News

Cepheid is collaborating with Combacte and MedImmune, to identify pneumonia bacteria in patients so they can be entered into clinical programmes more

News